← Leaderboards
Juntao Luo
University Of California At Davis
$5,259,094
Attributed
$5,916,143
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,916,143 · 5
By mechanism
R01$3,085,394 · 2
R42$1,314,098 · 1
R35$1,064,026 · 1
R21$452,625 · 1
Top collaborators
Most similar at University Of California At Davis
Same institution · by research overlap
- Kit S Lam$32,497,491
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsDesignFutureIn VitroIn VivoBaseCessation Of LifePreventSepsisComplexCytokine Release SyndromeInflammatoryNanotherapeuticImmuneStructureMolecularEvaluationPathway InteractionsHydrophobicityTissuesNanocarrierInflammationBiodistributionNanoformulation
Grant awards (16)
Aerosolized Chemically Modified Tetracycline Nanoformulation for the Treatment of Acute Respiratory Distress Syndrome$887,354
R42 · FY2025 · HL
Bioactive immune-modulating nanodrug for sepsis treatment$407,500
R35 · FY2025 · GM · contact PI
Bioactive immune-modulating nanodrug for sepsis treatment$407,500
R35 · FY2024 · GM · contact PI
Bioactive immune-modulating nanodrug for sepsis treatment$249,026
R35 · FY2024 · GM · contact PI
Aerosolized Chemically Modified Tetracycline Nanoformulation for the Treatment of Acute Respiratory Distress Syndrome$426,744
R42 · FY2023 · HL
An innovative hemoperfusion nanotrap for sepsis treatment.$377,423
R01 · FY2021 · GM · contact PI
An innovative hemoperfusion nanotrap for sepsis treatment.$380,151
R01 · FY2020 · GM · contact PI
An innovative hemoperfusion nanotrap for sepsis treatment.$388,800
R01 · FY2019 · GM · contact PI
An innovative hemoperfusion nanotrap for sepsis treatment.$388,800
R01 · FY2018 · GM · contact PI
Rational Design and High throughput synthesis of nanocarriers for efficient drug delivery$199,000
R21 · FY2016 · EB · contact PI
Rational Design and High throughput synthesis of nanocarriers for efficient drug delivery$253,625
R21 · FY2015 · EB · contact PI
Size-tunable cancer nanotherapeutics$311,403
R01 · FY2014 · CA · contact PI
Size-tunable cancer nanotherapeutics$301,772
R01 · FY2013 · CA · contact PI
Size-tunable cancer nanotherapeutics$321,034
R01 · FY2012 · CA · contact PI
Size-tunable cancer nanotherapeutics$320,531
R01 · FY2011 · CA · contact PI
Size-tunable cancer nanotherapeutics$295,480
R01 · FY2010 · CA · contact PI